Delivery Technology for Immunogenic Peptides
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
117
NCT01493050
The Effects of Sevelamer Carbonate on Diabetic Nephropathy
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 29, 2012
Completion: Dec 31, 2013
Loading map...